Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders.
Lieuwe de HaanMirjam van TrichtFloor van DijkCelso ArangoCovadonga M Díaz-CanejaJulio BobesLeticia García-ÁlvarezStefan LeuchtPublished in: Psychological medicine (2022)
We conclude that variation in individual proneness for an unfavorable SR is substantial and only modestly associated with symptomatic response. We need earlier identification of those most at risk for unfavorable SR and research into interventions to improve SR to antipsychotic medication in those at risk.